The Future of Drug Development is Quantum! (hosted by Singularity U San Diego)
Many believe that quantum computing is far in the future, but when it comes to drug discovery and development, the future is now.
Pharmaceutical development critically depends upon the latest computational tools. Most recently, pharma R&D has been looking to quantum computing (QC) for drug discovery, as one of the first commercial applications of this emerging field. QC is expected to be able to predict and simulate the structure, properties, and behavior (or reactivity) of these molecules more effectively than conventional computing can.
In this event, we will highlight the path forward toward quantum drug discovery. We will begin with a keynote speech by Mark Jackson, Ph.D., Quantum Evangelist at Cambridge Quantum, and then proceed to a panel discussion amongst industry experts. All interested parties are invited to attend, whether from the pharmaceutical, quantum, investment, or general technology fields.
Dr. Mark Jackson is the Quantum Evangelist at Cambridge Quantum. He received his B.S. in Physics and Mathematics from Duke University and Ph.D. in Theoretical Physics from Columbia University. He then spent 10 years researching superstring theory and cosmology, co-authoring almost 40 technical articles. He is Adjunct Faculty at Singularity University and a Director of Astronomers Without Borders.